Shares of Transition Therapeutics Inc. (TTHI) (TTH.TO) have gained nearly 25% in the last one month, as the company awaits phase II study results of its neuropsychiatric drug candidate – ELND005.
Forex – financial instrument.Forex news
Shares of Transition Therapeutics Inc. (TTHI) (TTH.TO) have gained nearly 25% in the last one month, as the company awaits phase II study results of its neuropsychiatric drug candidate – ELND005.